IND submission

Investigator’s brochure (IB) guide:  How to write and update an IB for clinical trials aligned with ICH E6(R3)

Developing and maintaining an Investigator’s Brochure requires the effective integration of evolving nonclinical, clinical, and manufacturing information. This guide explores the key considerations, processes, and…

From China to Global Markets: Preparing Biotech Assets for FDA and EMA

Explore the growing role of China-originated biotech assets and why early documentation strategy is key to global regulatory success.

Your IND Application Is Only as Strong as the Documents Behind It

A well-prepared IND is a signal of scientific credibility to future partners, investors, and licensing counterparts.

Journey To An IND Submission

The critical role of medical writing for regulatory interactions, nonclinical IND sections and preparing for clinical trials The path from drug discovery to…